Navigation Links
Shire Continues to Deliver Excellent Growth From Core Products
Date:10/30/2009

DUBLIN, October 30 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY) the global specialty biopharmaceutical company, announces results for the three months to September 30, 2009.

    Q3 2009 Financial Highlights

                                                               Q3 2009(1)

    Product sales                                        $603 million    -15%

    Product sales from core products(2)                  $532 million    +20%
    Product sales growth from core products at
    constant exchange rates(2)(3)                                        +23%

    Total revenues                                       $667 million    -14%

    Non GAAP operating income                            $134 million    -52%
    US GAAP operating income                              $92 million    -25%
    Non GAAP diluted earnings per ADS                           $0.49    -58%
    US GAAP diluted earnings per ADS                            $0.33  +$0.52

    (1) Figures compare Q3 2009 results with the same period in 2008.

    (2) Core products represent Shire's products excluding ADDERALL XR.

    (3) Sales growth at constant exchange rates ("CER"), which is a Non GAAP
        measure, is calculated after restating Q3 2009 results using Q3 2008
        average foreign exchange rates.

Angus Russell, Chief Executive Officer, commented:

"Shire continues to deliver excellent growth from its core products, which were up 20% over an exceptionally strong Q3 2008. This performance reflects our transformation in the past few years into a global biopharmaceutical company with a proven differentiated strategy and a balanced portfolio of new products which is protected by strong exclusivity and patent protection.

The growth of our core products and continued pro-active cost management are positioning us well to deliver on our unchanged guidance framework for 2009 and our aspiration of growing sa
'/>"/>

SOURCE Shire Plc
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related medicine technology :

1. Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients
2. Shire Enhances its Orphan Drug Pipeline With the Acquisition of a New Clinical Candidate for Metachromatic Leukodystrophy
3. Shire to Present Additional Scientific Data on ADHD Treatment Portfolio at American Psychiatric Association Annual Meeting
4. Shires Investigational Nonstimulant ADHD Treatment INTUNIV(TM) (Guanfacine Extended Release) Demonstrated Significant Efficacy in Reducing ADHD Symptoms at All Measured Time Points Up to 24 Hours Postdose
5. Shire Announces Approval of ELAPRASE(R) (idursulfase) in Brazil
6. Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent
7. Shire Withdraws European Application for DAYTRANA(TM) (Methylphenidate Transdermal System)
8. Shire Announces Study Results of the Effects of INTUNIV(TM) (Guanfacine) Extended Release on Secondary Measures in Children with ADHD and Oppositional Symptoms
9. Shire Presented Results of a New Database Analysis on Lialda(R) (Mesalamine) and Other 5-ASAs for Ulcerative Colitis at Digestive Disease Week
10. Shire has Filed a Treatment Protocol for Velaglucerase Alfa for Gaucher Disease
11. Shire Receives Fast Track Designation for velaglucerase alfa for Gaucher Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... 14, 2014 /PRNewswire-iReach/ -- Acumed,s new SLIC Screw System ... accompanying instrumentation to place and insert the screw accurately ... tissue (e.g. ligament) repair or reconstruction as it holds ... (Photo: http://photos.prnewswire.com/prnh/20140114/MN45636 ) The ... (spacing) of the scaphoid and lunate while allowing some ...
(Date:1/14/2014)... 2014 NineSigma , Inc., the leading ... Innovation Leadership Summit , May 14-16, 2014 at the ... Ohio . This is the ... to breakthrough achievements through open innovation. Participants will learn ... across disciplines and even across industries. ...
(Date:1/14/2014)... BETHESDA, Md. , Jan. 14, 2014 /PRNewswire/ ... solutions for the healthcare industry, announced that the ... Food and Drug Administration, has released its first ... (PRO) measure in drug development: Qualification of ... Measurement of Symptoms of Acute Bacterial Exacerbation of ...
Breaking Medicine Technology:Acumed introduces the Scapho-Lunate Inter Carpal (SLIC) Screw System 2Acumed introduces the Scapho-Lunate Inter Carpal (SLIC) Screw System 3Expect the Unexpected from Leading Global Innovators at NineSigma Leadership Summit, Sharing Winning Strategies to Advance Innovation 2Expect the Unexpected from Leading Global Innovators at NineSigma Leadership Summit, Sharing Winning Strategies to Advance Innovation 3Expect the Unexpected from Leading Global Innovators at NineSigma Leadership Summit, Sharing Winning Strategies to Advance Innovation 4Evidera Announces Release of FDA Draft Guidance on Use of the "EXACT" to Measure Symptoms of COPD Exacerbations 2Evidera Announces Release of FDA Draft Guidance on Use of the "EXACT" to Measure Symptoms of COPD Exacerbations 3Evidera Announces Release of FDA Draft Guidance on Use of the "EXACT" to Measure Symptoms of COPD Exacerbations 4
... Netherlands, SHENZHEN, China and HUIZHOU, China, Dec. 15, 2010 ... a new disposable wireless diagnostic test platform for consumer ... for pregnancy, fertility, pathogens, AIDS, drugs, allergens and even ... will enable much more rapid diagnoses for diseases and ...
... Inc. (Nasdaq: BNVI ) today announced the publication ... cells to glucose limitation" in the journal Cell Cycle ... of the protein CC3/TIP30 in cancer cells and their ability ... of glucose and other nutrients. Lack of CC3/TIP30 in a ...
Cached Medicine Technology:Cell Phones Are Now Personal Diagnostic Tools That Can Monitor Fertility, Pathogens, AIDS, Drugs, and Allergens 2Bionovo Announces Publication Describing How Metabolic Adaptability Contributes to the Metastasis of Tumors 2Bionovo Announces Publication Describing How Metabolic Adaptability Contributes to the Metastasis of Tumors 3
(Date:4/14/2014)... advances have been made in chemotherapy over the past ... healthy tissues continues to be a major challenge. ... delivery, including the use of nanocarriers, or capsules, that ... in the body. , The catch? These carriers are ... Change the size from 10 nanometers to 100 nanometers, ...
(Date:4/14/2014)... at Henry Ford Hospital reached a medical milestone ... replacement using a novel way to access the ... in the United States performing the unique procedure ... by temporarily connecting major blood vessels. , Northern ... first transcaval procedure on July 3, 2013 when ...
(Date:4/14/2014)... the 20th century, is currently losing a lot of ... at the University of South Carolina have just reported ... against so-called "superbugs." , Bacteria have been chipping away ... since their first wide-scale use as antibiotics in the ... the bacterium Staphylococcus aureus , was once readily ...
(Date:4/14/2014)... active role in their radiation treatment decisions leaves ... and may even relieve psychological distress around the ... Medicine at the University of Pennsylvania report ... a study of 305 patients undergoing radiation treatment, ... in the department in Radiation Oncology at Penn ...
(Date:4/14/2014)... web information on colorectal cancer is too difficult for ... appropriate risks to and concerns of patients, a study ... a review of a dozen popular websites, most of ... were written beyond the recommended sixth-grade reading level, while ... as well as the barriers to and benefits of ...
Breaking Medicine News(10 mins):Health News:Nano shake-up 2Health News:Henry Ford Hospital hits new heart valve surgery milestone 2Health News:Penicillin redux: Rearming proven warriors for the 21st century 2Health News:Penicillin redux: Rearming proven warriors for the 21st century 3Health News:Shared decision making during radiation therapy improves patient satisfaction 2Health News:Shared decision making during radiation therapy improves patient satisfaction 3Health News:Website information on colon cancer too complex, fails to address key concerns 2Health News:Website information on colon cancer too complex, fails to address key concerns 3
... -- The prestigious BBVA Foundation Frontiers of Knowledge Award ... J. Lefkowitz, M.D., James B. Duke Professor of Medicine ... investigator at Duke University Medical Center. This is only ... Dr. Lefkowitz,s research has affected millions of cardiac and ...
... U.S. Department of Energy,s National Nuclear Security Administration (NNSA) ... of radioisotopes, which are used to help millions of ... cancer, thyroid and heart disease. Earlier this week, ... develop a U.S. supply of Molybdenum-99 (Mo-99). Babcock & ...
... a new generation of products aimed at making cleaning ... in the current issue of Chemical & Engineering News ... Editor Michael McCoy points out in the cover story ... occurring despite a rocky economy in 2009, which led ...
... scent of urine could catch disease quickly , WEDNESDAY, Jan. 27 ... that can detect lung cancer simply on the basis of a ... is so far based solely on work with mice, but follow-up ... in the early diagnosis of lung cancer in humans. , "But ...
... ... regenerates dormant hair follicles to produce new growth is not being recommended by the researchers ... effective hair loss treatment options are already available. , ... (PRWeb UK) January 28, 2010 -- Researchers and hair restoration surgeons ...
... , WASHINGTON , Jan. 27 ... (SCAI) launched "WINHeart -- Score a WIN for Women," ... the diagnosis, treatment and survival of women with cardiovascular ... of interventional cardiologists within SCAI, today released a new ...
Cached Medicine News:Health News:Renowned Duke researcher wins Frontiers of Knowledge Award 2Health News:SNM applauds US Department of Energy's move to develop domestic radioisotope supply 2Health News:New Test Might 'Smell' Early Stage Lung Cancer 2Health News:New Test Might 'Smell' Early Stage Lung Cancer 3Health News:Hair Cloning Not Yet Recommended by Researchers Who Developed the Technique 2Health News:New Report and Survey Findings Highlight Why More Women Die From Heart Disease Than Men 2Health News:New Report and Survey Findings Highlight Why More Women Die From Heart Disease Than Men 3Health News:New Report and Survey Findings Highlight Why More Women Die From Heart Disease Than Men 4Health News:New Report and Survey Findings Highlight Why More Women Die From Heart Disease Than Men 5
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: